In8bio Market Capitalization from 2010 to 2025
| INAB Stock | USD 0.30 0.02 6.25% |
Check In8bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among In8bio's main balance sheet or income statement drivers, such as Net Interest Income of 0.0, Depreciation And Amortization of 2.2 M or Interest Expense of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.56. In8bio financial statements analysis is a perfect complement when working with In8bio Valuation or Volatility modules.
In8bio | Market Capitalization |
Latest In8bio's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of In8bio Inc over the last few years. It is In8bio's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in In8bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 21.47 M | 10 Years Trend |
|
Market Cap |
| Timeline |
In8bio Market Capitalization Regression Statistics
| Arithmetic Mean | 74,346,507 | |
| Geometric Mean | 72,550,676 | |
| Coefficient Of Variation | 20.28 | |
| Mean Deviation | 12,154,718 | |
| Median | 82,449,652 | |
| Standard Deviation | 15,077,224 | |
| Sample Variance | 227.3T | |
| Range | 41.2M | |
| R-Value | (0.70) | |
| Mean Square Error | 124.5T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | (2,214,148) | |
| Total Sum of Squares | 3409.8T |
In8bio Market Capitalization History
About In8bio Financial Statements
In8bio stakeholders use historical fundamental indicators, such as In8bio's Market Capitalization, to determine how well the company is positioned to perform in the future. Although In8bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in In8bio's assets and liabilities are reflected in the revenues and expenses on In8bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in In8bio Inc. Please read more on our technical analysis and fundamental analysis pages.
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York. In8Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:Check out the analysis of In8bio Correlation against competitors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.